Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine A... ( NEW BRUNSWICK N.J. May 7 /- In letter...)

Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009

Date:5/7/2009

NEW BRUNSWICK, N.J., May 7 /PRNewswire-FirstCall/ -- In letters to Senate Special Committee on Aging Chairman Herb Kohl (D-WI) and Senate Finance Committee Ranking Member Charles Grassley (R-IA), Johnson & Johnson today announced its support for the Physician Payments Sunshine Act of 2009 (S. 301). The company also committed to begin voluntarily disclosing payments made to physicians by its U.S. pharmaceutical, medical device and diagnostics companies.

"We are in favor of greater transparency regarding the relationships between healthcare companies and physicians," said Johnson & Johnson chairman and CEO William C. Weldon. "We continue to believe such transparency is in the best interest of patients, payers, other stakeholders in healthcare and the industry itself."

The U.S. pharmaceutical companies of Johnson & Johnson will begin voluntarily providing information about the payments that they make to physicians on their respective web sites beginning in the first half of 2010. Reporting will be expanded to include the company's U.S. medical devices and diagnostics units and will reflect the general provisions of the Physician Payment Sunshine Act by June 30, 2011.

"Since we first introduced the bill, there has been a groundswell of support from every corner. I wholeheartedly welcome the endorsement from Johnson & Johnson. Patients want to know that they can fully trust the relationship they have with their doctor. I am confident this legislation will pass during the 111th Congress," said Senator Herb Kohl (D-WI), Chairman of the Special committee on Aging.

Weldon said, "Greater transparency will enhance trust and recognition that collaborations between pharmaceutical and device manufacturers and physicians lead to important medical advances that save lives. I commend Senators Kohl and Grassley for a constructive exchange of ideas and look forward to continuing to work wi
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results

Post Your Comments:

(Date:12/1/2009)...FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a b...tary antibodies for the treatment of cancer, infla...at Bayer Schering Pharma AG has exercised its opti...eement entered into on January 12, 2009 to develop...mors. ,, Under the terms of the agreement, Baye...

(Date:11/30/2009)...ewswire/ -- Microban International, Ltd., the glob...tion, is pleased to announce their exclusive North...est U.S. manufacturer and distributor of ceramic t... two new lines of ceramic tile with OutStand Techn...g silver based technology, in order to create a li...

(Date:11/30/2009)...Newswire-FirstCall/ -- Nektar Therapeutics (Nasdaq...e Masuoka, M.D. to Senior Vice President and Chief...y to Nektar,s President and Chief Executive Office...g leadership and highly effective clinical develop...advancing Nektar,s proprietary clinical pipeline, ...

Breaking Medicine Technology:Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2 Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3 Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4 Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2 Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2 Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3 Midlife Heart Risk Factors Linked to Later Dementia 53613 1 Midlife Heart Risk Factors Linked to Later Dementia 53613 2 Midlife Heart Risk Factors Linked to Later Dementia 53613 3 CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 1 CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 2 CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 3 CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients 53611 4 More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 1 More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 2 More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 3 More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 4

[0] Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet [0] Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology [0] Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer

...BRISBANE, Australia, May 8 Implicit Bioscience Lt...tion of a manufacturing contract to support the ne...C14, a clinical-stage monoclonal antibody for acut...ty profile in over 150 patient exposures, and init...ly-ventilated patients has provided a clear ration...

...Isolagen(TM), Inc. (NYSE Amex: ILE ) today annou...ration ("FDA") has completed its initial review of...") related to its Nasolabial Fold/Wrinkles product...) the BLA for full review. , , In a communication...ed that it had completed its initial review of the...

Other Medicine Technology:CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 2 CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 3 CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License 4 Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 2 Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 3

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review

(Date:12/1/2009)... , Amadeus will operate a... Cedar Knolls, NJ (PRWEB) December 1, ... has completed the acquisition of all operating as...der in the development of enterprise governance, r...lutions, from DECIMAL, a corporate performance man...

(Date:12/1/2009)... , A new mind-body medici...itute (AMI) found that daily meditation, diaphragm...ive, and life-enhancing physical, mental and emoti...verill Park, NY (PRWEB) December 1, 2009 –&n...tudy found that meditation and yoga practices lear...

(Date:12/1/2009)... , , NEWPORT BEACH, Calif., Dec. 1 /PRN...lling code that insurers will reimburse them for t...n monitor for ,going under, for surgery. ,, Ane...nt brain monitoring is to avoid postop dementia fr...hesiologists have not heard the ,avoid over-medica...

(Date:12/1/2009)... , , SHENZHEN, China, Dec....ain,Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or "t...n China based on the number of directly operated s...ults for the third quarter ended,September 30, 200...January 2009, Nepstar terminated a voting rights a...

(Date:12/1/2009)... , CHICAGO A study using functional magnetic res...evealed that adults who were exposed to lead as ch...ere presented today at the annual meeting of the R...What we have found is that no region of the brain ...ad author, Kim Cecil, Ph.D., imaging scientist at ...

[0] Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions [0] New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga [0] 5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed [0] China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 [0] Childhood lead exposure causes permanent brain damage

...irst heart transplant patient whose donor heart wa... The pioneering operation was performed on the ...uth Wales on 20 February after her body rejected h...attached to it. The operation was performed by...

...gst Italian scientists to show that high cholester... though more studies to prove the same is welcome....on of male hormones that cause prostate cancer, wh...sk of getting afflicted with cancer The resea...

...winner of the prestigious Dada Saheb Phalke Award,...is afternoon. //The superstar had come in the lime...smuggler Veerappan for more than 100 days, about s...ysician Dr Ramana Rao said. Dr Bhujanga Shetty of ...

...ods it ahs been found that survival rates followin... three-fold when emergency medical// personnel use... Arizona Sarver Heart Center. Cardiocerebral Res...ael J. Kellum, MD, leading author of the study rep...

...in 2000 and was later recommendation for all child... in the rates of pneumonia among young infants. /...ease among children younger than 2 years of age wa...tion rate. But in the present study that was condu...

...ases are an urban lifestyle phenomenon, a three-ye... revealed that heart-related problems// are the la...ive leading institutes led by the Byrraju Foundati...se Control (CCDC), the CARE Foundation in India, t...

Other Medicine News:Health News:Donor Heart Gives Way for Patient’s Own Hear 2 Health News:Paramedics save more lives following unconventional rules 2 Health News:Mortality Rates Due To Heart Diseases Is High In Rural Areas Too 2

Donor Heart Gives Way for Patient’s Own Hear Fatal Attraction: Cholesterol linked To Prostate cancer Kannada Superstar Dr. Rajkumar's Eyes Donated As Per His Wish Paramedics save more lives following unconventional rules Pneumonia Vaccine Effective Among Children Mortality Rates Due To Heart Diseases Is High In Rural Areas Too

...to provide the surgeon with surgical solutions for...linically successful P.F.C. Total Knee System intr...f innovation.,Indicated for procedures where mech...cruciate ligament, the cruciate substituting compo...

BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock

Alpina® Total Knee System

OptiMumm™ Smoke Evacuator

Medicine Products:

PFC SIGMA Fixed Bearing Knee System Cruciate - Substituting BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock Alpina® Total Knee System OptiMumm™ Smoke Evacuator

Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine A...( NEW BRUNSWICK N.J. May 7 /- In letter...),Health